ストックスクリーナーアプリを入手
96.72
0.49%
0.47
アフターアワーズ：
96.77
0.05
+0.05%
前日終値:
$96.25
開ける：
$95.08
24時間の取引高:
2.73M
Relative Volume:
0.98
時価総額：
$12.06B
収益：
$692.26M
当期純損益:
$-512.41M
株価収益率:
-22.81
EPS:
-4.24
ネットキャッシュフロー:
$-274.36M
1週間 パフォーマンス:
+3.98%
1か月 パフォーマンス:
+52.46%
6か月 パフォーマンス:
+143.38%
1年 パフォーマンス:
+238.30%
1日の値動き範囲:
$92.54
$96.77
1週間の範囲:
$88.88
$100.22
52週間の値動き範囲:
$28.20
$100.22
Guardant Health Inc Stock (GH) Company Profile
GH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
96.72 | 12.13B | 692.26M | -512.41M | -274.36M | -4.24 |
|
TMO
Thermo Fisher Scientific Inc
|
572.41 | 212.64B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
209.94 | 148.81B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
708.45 | 56.99B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
146.74 | 41.81B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
210.46 | 35.91B | 15.90B | 1.28B | 2.21B | 7.2842 |
Guardant Health Inc Stock (GH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-25 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-09-22 | 再開されました | Wells Fargo | Overweight |
| 2025-04-10 | 開始されました | Mizuho | Outperform |
| 2025-01-23 | 開始されました | Barclays | Overweight |
| 2024-06-28 | アップグレード | Guggenheim | Neutral → Buy |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-04-24 | 再開されました | Craig Hallum | Buy |
| 2023-12-14 | 開始されました | Guggenheim | Neutral |
| 2023-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2023-11-13 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | 開始されました | Bernstein | Outperform |
| 2023-09-27 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-05-26 | アップグレード | Citigroup | Neutral → Buy |
| 2023-05-05 | 開始されました | UBS | Buy |
| 2023-03-09 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-01-05 | 開始されました | Scotiabank | Sector Outperform |
| 2022-11-01 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | 開始されました | Craig Hallum | Buy |
| 2022-10-06 | 開始されました | Stephens | Overweight |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-06-03 | 開始されました | Piper Sandler | Overweight |
| 2022-04-28 | 再開されました | BTIG Research | Buy |
| 2022-02-24 | 繰り返されました | Canaccord Genuity | Buy |
| 2022-02-24 | 繰り返されました | Citigroup | Buy |
| 2022-02-24 | 繰り返されました | Cowen | Outperform |
| 2022-02-24 | 繰り返されました | Morgan Stanley | Overweight |
| 2022-02-24 | 繰り返されました | SVB Leerink | Outperform |
| 2022-02-24 | 繰り返されました | Stifel | Buy |
| 2022-02-24 | 繰り返されました | Wells Fargo | Overweight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-06-15 | 開始されました | Raymond James | Mkt Perform |
| 2021-06-03 | 開始されました | Goldman | Buy |
| 2021-05-25 | 開始されました | Wells Fargo | Overweight |
| 2021-01-11 | 開始されました | Stifel | Buy |
| 2020-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2020-06-12 | 開始されました | BTIG Research | Buy |
| 2020-02-21 | 開始されました | Guggenheim | Buy |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-08-07 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-04-16 | 開始されました | Canaccord Genuity | Buy |
| 2019-04-10 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | 繰り返されました | BofA/Merrill | Neutral |
| 2018-10-29 | 開始されました | BofA/Merrill | Neutral |
| 2018-10-29 | 開始されました | JP Morgan | Overweight |
| 2018-10-29 | 開始されました | William Blair | Outperform |
すべてを表示
Guardant Health Inc (GH) 最新ニュース
Relative strength of Guardant Health Inc. in sector analysis2025 Trade Ideas & Weekly Watchlist for Hot Stocks - newser.com
Why Guardant Health Inc. (5GH) stock could outperform next yearJuly 2025 Sentiment & Community Verified Trade Alerts - newser.com
Sentiment analysis tools applied to Guardant Health Inc.July 2025 Action & Community Consensus Stock Picks - newser.com
Is Guardant Health Inc. (5GH) stock a fit for income portfoliosMarket Trend Report & Reliable Entry Point Alerts - newser.com
Guardant Health to Participate in Upcoming Investor Conferences - The Joplin Globe
Key metrics from Guardant Health Inc.’s quarterly dataTrade Risk Report & Expert Approved Momentum Trade Ideas - newser.com
Will Guardant Health Inc. stock split again soonShort Setup & AI Enhanced Trade Execution Alerts - newser.com
Using AI based signals to follow Guardant Health Inc.Dip Buying & Risk Controlled Stock Alerts - newser.com
New Study Validates Guardant Reveal Blood Test’s Effectiveness in Monitoring Chemotherapy Response - BioSpace
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 01net
Can volume confirm reversal in Guardant Health Inc.Weekly Stock Analysis & Short-Term High Return Ideas - newser.com
How Guardant Health Inc. (5GH) stock correlates with oil marketsQuarterly Trade Summary & Free Verified High Yield Trade Plans - newser.com
Stocks making big moves yesterday: Clover Health, Rivian, Johnson Controls, Kratos, and Guardant Health - The Globe and Mail
New Study Validates Guardant Reveal Blood Test's Effectiveness in Monitoring Chemotherapy Response - MarketScreener
New study validates Guardant Reveal blood test's effectiveness in monitoring chemotherapy response - MarketScreener
Guardant Health (NASDAQ: GH) study shows 2.3-month median lead in progression detection - Stock Titan
Will Guardant Health Inc. stock go up soonJuly 2025 Retail & Free Safe Entry Trade Signal Reports - newser.com
How supply shortages influence Guardant Health Inc. (5GH) stock2025 Stock Rankings & Community Trade Idea Sharing Platform - newser.com
Guardant Health prices upsized $350 million convertible notes offering By Investing.com - Investing.com Nigeria
Guardant Health Inc. stock trendline breakdownJuly 2025 Big Picture & Low Drawdown Investment Ideas - newser.com
Can Guardant Health Inc. (5GH) stock deliver strong annual returnsTrade Analysis Report & Long-Term Safe Investment Plans - newser.com
Is Guardant Health Inc. (5GH) stock a top hedge fund pickMarket Movers & Low Drawdown Momentum Trade Ideas - newser.com
Guardant Health prices upsized $300 million common stock offering By Investing.com - Investing.com Nigeria
Why Guardant Health Inc. stock is recommended by analysts2025 Retail Activity & Real-Time Volume Triggers - newser.com
Guardant Health prices upsized $350 million convertible notes offering - Investing.com India
Guardant Health (GH) Blood Test Shows High Adherence for Colorec - GuruFocus
Guardant Health plans to offer $300 million in convertible notes By Investing.com - Investing.com Australia
Guardant Health launches $250 million common stock offering By Investing.com - Investing.com
Guardant Health (Nasdaq: GH): 95% adherence in 20,000 Shield CRC blood screening patients - Stock Titan
Guardant Health Reaches New 52-Week High of $95.88, Up 207% - Markets Mojo
Guardant Health Shares Drop After $350M Notes, Stock Offering | 2025News and Statistics - IndexBox
Why Guardant Health (GH) Shares Are Sliding Today - Yahoo Finance
Guardant Health stock falls after pricing upsized convertible notes offering By Investing.com - Investing.com UK
Guardant Health stock falls after pricing upsized convertible notes offering - Investing.com
Market Participants Recognise Guardant Health, Inc.'s (NASDAQ:GH) Revenues Pushing Shares 56% Higher - 富途牛牛
GH: Key Insights on Recent Underwriting Developments - GuruFocus
How risky is Guardant Health Inc. stock now2025 Earnings Surprises & Stepwise Trade Signal Guides - newser.com
Guardant Health Ramps Up Fundraising With Stock And Note Offerings - Finimize
Guardant Health Prices Upsized Offering at $90 per Share - MarketScreener
Guardant Health prices upsized $350.0 million convertible senior notes offering - MarketScreener
Guardant Health Prices Upsized $350.0 Million Convertible Senior Notes Offering - The AI Journal
Guardant Health Announces Pricing of Upsized Public Offering of Common Stock - The AI Journal
Guardant Health Inc (GH) 財務データ
収益
当期純利益
現金流量
EPS
Guardant Health Inc (GH) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| MIGNONE ROBERTO | Director |
Oct 21 '25 |
Option Exercise |
0.00 |
3,167 |
0 |
3,167 |
| Hidalgo Medina Manuel | Director |
Oct 17 '25 |
Option Exercise |
0.00 |
232 |
0 |
1,315 |
| Tariq Musa | Director |
Oct 17 '25 |
Sale |
66.95 |
116 |
7,766 |
7,725 |
| POTTER MYRTLE S | Director |
Oct 17 '25 |
Sale |
66.95 |
26 |
1,741 |
18,324 |
1.69%
0.02%
大文字化:
|
ボリューム (24 時間):